ST. PAUL, Minn.--(BUSINESS WIRE)--Every vascular catheter used on a patient poses potential for a costly and prevalent central line-associated bloodstream infection (CLABSI). Passive disinfection caps ...
SAN DIEGO, CA--(Marketwired - Feb 12, 2015) - Ivera Medical announced today that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for a new patent for its ...
The FDA granted 510(k) clearance to Ivera Medical’s Curos disinfecting port protector, designed to reduce hospital-acquired catheter related bloodstream infections, according to a company news release ...
SAN DIEGO, CA--(Marketwired - Jul 8, 2014) - Ivera Medical announced that there was a significant endorsement of alcohol-impregnated port protectors, which Ivera pioneered with its Curos ® device. The ...
New Patent for Curos Disinfecting Port Protectors to be issued June 26, 2012 by USPTO June 13, 2012 Ivera Medical Corporation announced today that the United States Patent & Trademark Office (USPTO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results